Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Wascher, TC; Paulweber, B; Toplak, H; Saely, CH; Drexel, H; Föger, B; Hoppichler, F; Stulnig, T; Stingl, H; Clodi, M, , Ausschuss, Leitlinien.
[Lipids-Diagnosis and therapy in diabetes mellitus (Update 2023)].
Wien Klin Wochenschr. 2023; 135(Suppl 1): 157-160.
Doi: 10.1007/s00508-023-02166-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Wascher Thomas
- Co-authors Med Uni Graz
-
Toplak Hermann
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Hyper- and dyslipidemia contribute to cardiovascular morbidity and mortality in diabetic patients. Pharmacological therapy to lower LDL cholesterol has convincingly shown to reduce cardiovascular risk in diabetic patients. The present article represents the recommendations of the Austrian Diabetes Association for the use of lipid-lowering drugs in diabetic patients according to current scientific evidence.
- Find related publications in this database (Keywords)
-
Hyperlipidemia
-
Statins
-
Diabetes mellitus